SERVING SUBSTANCE EXPOSED NEWBORNS IN HARFORD COUNTY

Similar documents
Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Child Welfare and MOMS: Building Partnerships to Improve Care

Substance-Exposed Newborns

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay

Substance-Exposed Newborns

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

Tuscarawas County Health Department. Vivitrol Treatment Consent

Childbirth and Parenting

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Methadone and Pregnancy

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Buprenorphine & Controlled Substance Treatment Agreement

Effects of Prenatal Illicit Drug. Use on Infant and Child

MOMS Project Panel Overview

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

A New approach to NAS: home in 6 days

Neonatal Drug Withdrawal

Brief History of Methadone Maintenance Treatment

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Opioids Research to Practice

Understanding Prenatal Drug Exposure

Opioid Use and Other Trends

Neonatal Abstinence Syndrome:

Childbirth and Parenting

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Aetna s Initiative on the Opioid Epidemic

STATE OF FLORIDA DEPARTMENT OF HEALTH ORDER OF EMERGENCY RESTRICTION OF LICENSE. Celeste Philip, M.D., M.P.H., State Surgeon General, ORDERS the

Neonatal Abstinence Syndrome (NAS)

Substance Abuse Suboxone Treatment

Neonatal Abstinence Syndrome:

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

Substance-Exposed Newborn

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Patient and Family Agreement on Opioids

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Opioid Task Force Kick-Off Meeting. February 29, 2016

Outcomes of Infants with Neonatal Abstinence Syndrome

Cuyahoga County Division of Children and Family Services (CCDCFS) Policy Statement

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS

EI Leadership April 24, 2018

Development and use of the Eating, Sleeping, Consoling (ESC) Care. for opioid-exposed newborns and their families in Northern New England

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Standards of Care Inventory (CARICOM)/DTC Luis Alfonzo Demand Reduction Specialist CICAD OAS

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Prescription Drug Impact in the Workplace

MAT in the Corrections Setting

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Wales Neonatal Network Guideline

Addressing Substance Use Among Pregnant Women and New Moms

Opioid Prescription and Illicit Drug Overdoses: On the Rise

By Richard Harris, Assistant Director. May 21, 2010

NOW CANADA SOCIETY TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) FAX (250)

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

The Importance of Psychological Treatment and Behavioral Support

Vivitrol Drug Court and Medication Assisted Treatment

Presenter. Key Provisions of CAPTA. Substance-Exposed Newborns, Mothers, and Child Welfare: Collaborative Strategies in Response to CAPTA

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

Patient Agreement for the use of Opioid Medications

Patient Information Leaflet

Nursing Care of the NAS Infant. Lori Markham MSN, MBA, ARNP, NNP-BC

Welcome to The Woodlands Great Oaks Tall Trees

IN-PATIENT PEDIATRIC REHABILITATION

Methadone/ Suboxone Treatment in federal prison

Neonatal Abstinence Syndrome Epidemiology, diagnosis, management and prevention

Fighting Today s Opioid Epidemic

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Prepublication Requirements

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Neonatal Abstinence: The epidemic Its Impact on All of Us

Enhanced Substance Abuse Management in Higher Risk Populations

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP

FIRST STEPS TREATMENT CENTER. David Moran CACD, LCSW, TEP Crozer-Chester Medical Center

REFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre.

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

Hospitals Role in Addressing the Opioid Crisis

Session 7: Opioids and Club Drugs 7-1

Recommendations for Components of Emergency Department Discharge Protocols

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS)

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Methadone Treatment. in federal prison

GOALS AND OBJECTIVES

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

Transcription:

SERVING SUBSTANCE EXPOSED NEWBORNS IN HARFORD COUNTY A Snapshot of the Data, Services, and Outcomes Jerome M. Reyerson, LCSW-C Director, Harford County Department of Social Services

GLIMPSE OF A SUBSTANCE EXPOSED NEWBORN https://youtu.be/4o3bb5tfo0a 2

PHILOSOPHICAL APPROACH TO SERVING SUBSTANCE EXPOSED NEWBORNS The Department of Social Services response is based on assessing imminent risk to the child, connecting families to services in order to prevent harm to the child, and preventing placement of the child outside the home unless there are no other options. The Department of Social Services response in substance exposed newborn cases is a Risk of Harm Assessment NOT an investigation (unless there are additional risk factors present). It is rare that a substance exposed newborn is removed from the home at delivery. The vast majority of Substance Exposed Newborns remain in the home. 3

SNAPSHOT OF HCDSS SUBSTANCE EXPOSED NEWBORNS DATA 180 160 140 120 100 80 60 FY 2016 FY 2017 FY 2018 40 20 0 Total SEN Referrals Total SEN Referrals Accepted Total Overall Placements Total SEN Placements Data Point FY 2016 FY 2017 FY 2018 % change Total SEN Referrals 135 154 170 26% Total SEN Referrals Accepted 87 111 129 48% Total Overall placements 96 84 106 26% Total SEN Placements 15 9 4 (-73%) 4

SUBSTANCE EXPOSED NEWBORN ASSESSMENTS 5 During a SEN Assessment: -The worker will make visits to the hospital and home -The worker assesses the safety, risk and wellbeing of the newborn and refers the family to appropriate services -Refer clients to substance abuse treatment and mental health treatment if needed -Coordinate with service providers -Communicate with medical personnel regarding the newborn s needs

SUBSTANCE EXPOSED NEWBORN ASSESSMENTS -Make referrals to community resources such as Healthy Families, Peer Recovery, Health Department Home Visiting, Infants & Toddlers & Family Recovery Court -Send parents for random urine screens as needed -Schedule Family Involvement Meetings when appropriate At the end of the sixty day assessment the case is either closed or transferred to In Home Consolidated Services 6

MEDICAL CONSIDERATIONS FOR SUBSTANCE EXPOSED NEWBORNS Substance Exposed Newborns experience withdrawal from all opiate based substances: Withdrawal symptoms often include-tremors, excessive, hard to console crying, vomiting, diarrhea, poor feeding, poor sleeping The newborns body cannot differentiate between legal and illegal substances. At delivery the baby is immediately cut off from the daily dose of opiates that it has become dependent on. Withdrawal symptoms from prescribed opiates are often more severe than withdrawal symptoms from street drugs such as heroin Withdrawal symptoms can present at birth and can last for weeks and sometimes months and years. Infants can also exhibit withdrawal like symptoms from non-opiate medications-xanax, valium, anti-depressants, THC, tobacco, and amphetamines 7

UNIVERSAL TESTING AND UNIVERSAL REPORTING A substance exposed newborn AND a substance using mom creates a perfect storm, which substantially elevates the risk for baby. *Once discharged home a substance exposed newborn has an increased risk for: Hospital readmission Sudden infant Death (SIDS/SUID) Shaken Baby Syndrome Physical Abuse Post Partum depression can worsen underlying and often untreated mental health issues and increase a women s risk of relapse Universal toxicology screening and reporting of moms and newborns provides a non-biased approach for assessing safety and ensuring all families have access to all available resources.

UM UCMC FAMILY BIRTHPLACE POLICY A urine toxicology screening is completed on all moms on admission. If a mom has taken an Opioid medication, prescription or illegal, within two weeks of delivery the newborn is admitted to the Special Care Nursery (SCN) at 24 hours of life or sooner For short acting prescription opioid medications, infants remain in the SCN until they are at least 72 hours old. For Long acting prescription opioid medications, such as methadone and buprenorphine infants remain in the SCN for at least 5-7 days Breastfeeding is encouraged and supported in all moms as long as they are using the substance legally, HIV- and have no other illegal substances in their urine. 9

SUBSTANCE EXPOSED NEWBORN FAMILY INVOLVEMENT Our Social Worker meets with all moms Newborns are cared for by specially trained nursing and physician staff who welcome and encourage family participation 24 hour visitation for parents and we encourage parents to be actively involved in their baby s care. We offer parents 3 stork nights with meal vouchers Peer Recovery specialist and mental health services on site. Hospital Family meeting when needed Infant CPR, car seat training and newborn classes available through the hospital OR contact us for onsite training at your facility. Classes for staff, parents and families available.

CARE OF THE SUBSTANCE EXPOSED NEWBORNS Dark, quiet room, Limit over stimulation Tight swaddling/holding, Swings/bouncy seats Skin to Skin encouraged Frequent diaper changes Smaller, more frequent feeds Infant Massage Cuddler Program For infants with moderate to severe withdrawal medication is sometimes required. Morphine, Clonidine and Phenobarbital are the most common medication used. Parents are taught-newborn stress cues, how to care for a fussy baby, Newborn Massage and Feeding Techniques Hold Them Close Program- Prior to Discharge each family receives a bag of baby safety and developmental supplies PLUS safe sleep, shaken baby and general newborn safety teaching and a bag of books for home

This is our chance to make a difference in the lives of all babies and families here in Maryland 12 https://youtu.be/4o3bb5tfo0a

WHO S WHO AT HCDSS CONTACT INFORMATION SEN Specialist: Family Recovery Court Clinical Coordinator Bethany Fisher, LGSW Tara Guthrie, LCSW-C bethany.fisher@maryland.gov tara.guthrie@maryland.gov 410-836-4933 410-836-4925 SEN Assessor: SEN Reunification Facilitator Jennifer Linsey, LGSW Family Recovery Court Clinical Coordinator-Interim jennifer.linsey@maryland.gov Denise Jirak-Smith, BSW 410-836-4755 denise.jirak-smith@maryland.gov 410-836-4785 Supervisor: Janice Cavanaugh, LCSW-C Case Associate janice.cavanaugh@maryland.gov Staci Scoggin 410-836-4920 staci.scoggin@maryland.gov (443) 910-1757 Child Welfare Court Specialist Aimee Hiteshew, LBSW Case Associate aimee.hiteshew@maryland.gov Katherine Duley 410-836-4984 katherine.duley@maryland.gov 13